Morphine in tardive and idiopathic dystonia

Berg, D.; Becker, G.; Naumann, M.; Reiners, K.
September 2001
Journal of Neural Transmission;Sep2001, Vol. 108 Issue 8/9, p1035
Academic Journal
Summary. Opioids have been shown to improve L-Dopa induced dyskinesias in patients with Parkinson's disease. In this pilot trial of five patients with tardive and four patients with idiopathic dystonia we tested the effect of morphinsulfate in a retarded form with a dosage of 20–60 mg per day. A substantial improvement of dystonic movements could be observed in four patients with tardive and one patient with idiopathic dystonia. The effect was only transient in tardive dystonia while pain relief mediated by morphine overlasted the effect on involuntary movements.


Related Articles

  • Levodopa Response and Prognosis in Parkinson's Disease. Henchcliffe, Claire // Neurology Alert;Sep2007, Vol. 26 Issue 1, p5 

    The authors identified 97 autopsy-proven Parkinson's disease (PD) cases from the Queen's Square Brain Bank between 2001 and 2006, all with long-term levodopa treatment and rigorous clinical documentation. Clinical features were evaluated by chart review. Cerebral pathology was determined by:...

  • Long term motor complications of levodopa: clinical features mechanisms, and management strategies. Thanvi, B. R.; T. C. N. Lo // Postgraduate Medical Journal;Aug2004, Vol. 80 Issue 946, p452 

    Levodopa is the most effective symptomatic treatment of Parkinson's disease. However, after an initial period of dramatic benefit, several limitations become apparent including, dopa resistant motor symptoms (postural abnormalities, freezing episodes, speech impairment), "dopa resistant"...

  • Levodopa/benserazide withdrawal.  // Reactions Weekly;5/7/2005, Issue 1050, p13 

    Provides information on a case involving a man with Parkinson's disease who experienced episodes of dystonia or Pisa syndrome after levodopa/benserazide withdrawal. Drug dosage; Characteristics of episodes of dystonia.

  • Fluoxetine.  // Reactions Weekly;4/23/2005, Issue 1048, p12 

    Discusses a case report of a 77-year-old man with a history of depression who developed parkinsonism and orofacial dystonia and dyskinesia after his fluoxetine was increased. Reference to a study by J. J. Chen et al, published in the February 2005 issue of the "Journal of Clinical Psychiatry";...

  • 1997 Royal College mealist in medicine.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS112 

    Presents an abstract of the research manuscript `Experimental investigation of levodopa-induced dyskinesia in a primate model of Parkinsonism,' by P.J. Blanchet.

  • Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania. Dotchin, Catherine; Jusabani, Ahmed; Walker, Richard // Journal of Neurology;Sep2011, Vol. 258 Issue 9, p1649 

    It was previously thought that the prevalence of Parkinson's disease (PD) in developing countries, and in particular sub-Saharan Africa (SSA), was lower than the rest of the world. The Hai PD prevalence project [] diagnosed 32 patients (the majority previously undiagnosed and untreated) with PD...

  • Profile of idiopathic parkinson's disease in Moroccan patients. Regragui, Wafa; Lachhab, Lamiae; Razine, Rachid; Raissouni, Leila; Rasmouni, Khaoula; Imounan, Fatima; Ait Benhaddou, El hachmia; Abouqal, Redouane; Benomar, Ali; Yahyaoui, Mohamed // International Archives of Medicine;2014, Vol. 7 Issue 1, p1 

    Objective To characterize clinical aspects of Idiopathic Parkinson's disease from a movement disorders consultation in University Hospital of Rabat. Methods Retrospective review of medical records of 117 patients with diagnosis of Idiopathic Parkinson's disease seen in our outpatient clinic from...

  • TIPS for Patients With Parkinson's Disease.  // Neurology Reviews;Aug2011, Vol. 19 Issue 8, p16 

    The article presents effective tips and suggestions for patients with idiopathic Parkinson's disease regarding disease management and treatment. It indicates that walking is an essential adjunctive therapy for patients with Parkinson's disease. It suggests that sipping liquid carbidopa-levodopa...

  • Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism. Klintenberg, R.; Svenningsson, P.; Gunne, L.; Andrén, P. E. // Journal of Neural Transmission;Oct2002, Vol. 109 Issue 10, p1295 

    Summary. Using in situ hybridization, it was found that subchronic treatment with levodopa/benserazide increased preproenkephalin-A and preproenkephalin-B mRNAs in the dopamine-depleted striatum. In order to examine whether dysfunction of the endogenous opioid system may underlie the development...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics